BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 223 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2022. The put-call ratio across all filers is 1.73 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $23,318,201 | -10.7% | 464,321 | +12.3% | 1.41% | -0.7% |
Q2 2023 | $26,122,266 | +61.8% | 413,327 | +15.2% | 1.42% | +48.5% |
Q1 2023 | $16,143,312 | +20.5% | 358,820 | +17.4% | 0.95% | +15.1% |
Q4 2022 | $13,393,111 | -19.9% | 305,709 | +20.5% | 0.83% | -21.5% |
Q3 2022 | $16,713,000 | -29.8% | 253,645 | +14.1% | 1.06% | +25.9% |
Q4 2021 | $23,802,000 | -5.7% | 222,217 | -9.5% | 0.84% | -4.0% |
Q3 2021 | $25,246,000 | +16.9% | 245,557 | 0.0% | 0.87% | +23.6% |
Q2 2021 | $21,599,000 | -20.4% | 245,557 | -12.0% | 0.71% | -21.4% |
Q1 2021 | $27,126,000 | -14.2% | 278,986 | -1.0% | 0.90% | -18.1% |
Q4 2020 | $31,597,000 | -6.5% | 281,739 | -22.7% | 1.10% | -26.6% |
Q3 2020 | $33,777,000 | +21.2% | 364,373 | +2.0% | 1.50% | +13.8% |
Q2 2020 | $27,870,000 | +31.0% | 357,302 | -1.8% | 1.32% | -1.3% |
Q1 2020 | $21,273,000 | – | 363,772 | – | 1.33% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Boxer Capital, LLC | 705,159 | $12,728,000 | 12.46% |
BVF INC/IL | 2,640,251 | $47,657,000 | 11.79% |
Casdin Capital, LLC | 321,300 | $5,799,000 | 6.66% |
Opaleye Management Inc. | 220,000 | $3,971,000 | 2.48% |
PFM Health Sciences, LP | 1,420,511 | $25,640,000 | 0.79% |
Perceptive Advisors | 404,404 | $7,299,000 | 0.64% |
Partner Investment Management, L.P. | 18,788 | $339,000 | 0.55% |
Visium Asset Management, LP | 1,265,025 | $22,834,000 | 0.39% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 661,717 | $11,944,000 | 0.39% |
Virtus ETF Advisers LLC | 10,484 | $189,000 | 0.26% |